This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Memorial Sloan Kettering Cancer Center, Yeda Research and Develpment & Co. Ltd. Active years: 2022.
Company Filing History:
1 out of 618 
1 out of 1,168 Years Active: 2022
Title: Lilach Agemy: Innovator in Cancer Treatment
Introduction
Lilach Agemy is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on combinational therapies that aim to enhance the effectiveness of cancer treatments.
Latest Patents
Lilach Agemy holds a patent for "Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative." This patent describes an anti-myeloid-derived suppressor cells agent (anti-MDSCs agent) and a bacteriochlorophyll derivative (Bchl-D) used in combination therapy for cancer. The method involves administering the anti-MDSC agent and the Bchl-D sequentially, followed by photodynamic therapy (PDT) or vascular targeted PDT (VTP).
Career Highlights
Throughout her career, Lilach has worked with esteemed organizations such as Yeda Research and Development Company and Memorial Sloan Kettering Cancer Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field of cancer research.
Collaborations
Lilach Agemy has collaborated with notable colleagues, including Avigdor Scherz and Yoram Salomon. These partnerships have contributed to her innovative approaches in cancer treatment.
Conclusion
Lilach Agemy's work in combinational therapies represents a significant advancement in cancer treatment. Her dedication to research and collaboration with other experts continues to pave the way for innovative solutions in the fight against cancer.